Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 16, 2020
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutationsRebecca D Chernock, Barbara Rivera, Nicla Borrelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2022
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tractYing-Ju Kuo, James S Lewis, Tra Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
JCI Insight|February 9, 2026
Tracing the molecular route to progression in miRNA-biogenesis-defective thyroid lesionsAnne-Sophie Chong, Carla Roca, Paula Morales-Sánchez, et al.
The American Journal of Surgical Pathology|December 25, 2024
DEK :: AFF2 Fusion Sinonasal and Skull Base Nonkeratinizing Squamous Cell Carcinoma : A Clinical Outcome Study Compared With Conventional Sinonasal Squamous Cell CarcinomaStephanie A Hart, Jen-Fan Hang, Rebecca D Chernock, et al.
Nature Communications|September 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy targetCong Fu, Robert Saddawi-Konefka, Jordan M Chinai, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Pageof 8